Skip to content
Screener

Gain Therapeutics GANX Q1 2026 earnings

Reported May 11, 2026 · Before market open

EPS-$0.13In line
Revenue estimate$33.3K
EPS estimate-$0.13

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$33.3K
EPS estimate-$0.13

FAQ

When did Gain Therapeutics report Q1 2026 earnings?
Gain Therapeutics (GANX) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Gain Therapeutics's Q1 2026 revenue and EPS?
Gain Therapeutics reported eps of $-0.13 for Q1 2026.
Did Gain Therapeutics beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.13 by $0.00.
How did Gain Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 18.8% from $-0.16.
Where can I find Gain Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-058636) and the 10-Q periodic report (0001104659-26-058649) directly on SEC EDGAR. The filing index links above go to sec.gov.